Patel Digishaben D, Parchwani Deepak, Vachhani Uday, Parchwani Tanishk, Raghavani Pratik, Rajput Ajay, Dholariya Sagar, Singh Ragini
All India Institute of Medical Sciences, Rajkot, Gujarat India.
GMERS Medical College, Himmatnagar, Gujarat India.
Indian J Clin Biochem. 2022 Jul;37(3):319-327. doi: 10.1007/s12291-021-00997-8. Epub 2021 Aug 3.
Murine studies stipulate Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN-1) as a key mediator of PTH mRNA stability and is acknowledged by genome-wide-association-studies as secondary hyperparathyroidism defining trait in chronic kidney disease. Therefore, we hypothesize that molecular variants of the PIN-1 gene might affect the incidence and predisposition to secondary hyperparathyroidism in chronic renal insufficiency. A total of 281 adult participants, including 124 chronic kidney disease patients with secondary hyperparathyroidism and 157 healthy controls, were genotyped using polymerase chain reaction-restriction fragment length polymorphism method to unravel the effects of genetic risk loci (PIN-1 gene; - 667C > T; rs2233679) on the susceptibility to secondary hyperparathyroidism in chronic kidney disease. Suitable descriptive statistics was used for different variables. The genotype (x: 8.03, 2 d. f. = 0.0181) and allele distribution (x: 7.27, 2 d. f. : 0.007) of the - 667C > T variant differed significantly in cases and controls, with no deviation from Hardy-Weinberg equilibrium in either affected or control group. The observed frequencies of T allele of PIN-1 - 667 C > T SNP was significantly high in CKD-SHPT group compared to control group (52.41% vs. 41.71%; : 0.0118). TT variant of PIN-1 - 667C > T SNP was associated with increased risk for occurrence of CKD-SHPT in univariate analysis (OR: 4.6, : 0.0032, 95% CI: 1.66-12.76). Further in multivariate analysis, both TT (OR: 3.84, : 0.002, 95% CI: 0.79-9.26) and CT + TT (OR: 2.51, : 0.031, 95% CI: 0.64-8.68) variants were independently associated with increased risk for CKD-SHPT, emphasizing the deleterious effect of minor T allele. Serum PTH, phosphorus levels were significantly high in CT and TT genotypes compared to CC genotype of PIN-1 - 667C > T SNP ( = 0.001). PIN-1 promoter functional SNP (- 667C > T; rs2233679) appeared to be an important genetic determinant in etiopathogenesis of CKD-SHPT and genetic variants of this SNP influences the risk stratification and might serve as a predictive marker. Thus, rs2233679 can be useful for outcome predictions during diagnostic processes.
小鼠研究表明肽基脯氨酰顺反异构酶NIMA相互作用蛋白1(PIN-1)是甲状旁腺激素(PTH)mRNA稳定性的关键调节因子,全基因组关联研究也证实其为慢性肾脏病继发性甲状旁腺功能亢进的定义性特征。因此,我们推测PIN-1基因的分子变异可能影响慢性肾功能不全患者继发性甲状旁腺功能亢进的发生率和易感性。本研究共纳入281名成年受试者,其中包括124例患有继发性甲状旁腺功能亢进的慢性肾脏病患者和157名健康对照者,采用聚合酶链反应-限制性片段长度多态性方法进行基因分型,以探究遗传风险位点(PIN-1基因;-667C>T;rs2233679)对慢性肾脏病继发性甲状旁腺功能亢进易感性的影响。对不同变量采用了适当的描述性统计方法。-667C>T变异的基因型(χ²:8.03,自由度为2,P = 0.0181)和等位基因分布(χ²:7.27,自由度为2,P = 0.007)在病例组和对照组中存在显著差异,且患病组和对照组均未偏离哈迪-温伯格平衡。与对照组相比,慢性肾脏病继发性甲状旁腺功能亢进(CKD-SHPT)组中PIN-1 -667 C>T单核苷酸多态性(SNP)的T等位基因观察频率显著更高(52.41% 对 41.71%;P = 0.0118)。在单因素分析中,PIN-1 -667C>T SNP的TT变异与CKD-SHPT发生风险增加相关(比值比:4.6,P = 0.0032,95%置信区间:1.66 - 12.76)。进一步在多因素分析中,TT(比值比:3.84,P = 0.002,95%置信区间:0.79 - 9.26)和CT + TT(比值比:2.51,P = 0.031,95%置信区间:0.64 - 8.68)变异均与CKD-SHPT风险增加独立相关,强调了次要T等位基因的有害作用。与PIN-1 -667C>T SNP的CC基因型相比,CT和TT基因型的血清PTH、磷水平显著更高(P = 0.001)。PIN-1启动子功能性SNP(-667C>T;rs2233679)似乎是CKD-SHPT发病机制中的一个重要遗传决定因素,该SNP的基因变异影响风险分层,可能作为预测标志物。因此,rs2233679在诊断过程中对结果预测可能有用。